María
Quindós Varela
Publicacións (25) Publicacións de María Quindós Varela
2024
-
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583
-
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical and Translational Oncology
-
Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Journal of Clinical Oncology
-
SEOM-GEICO Clinical Guidelines on cervical cancer (2023)
Clinical and Translational Oncology, Vol. 26, Núm. 11, pp. 2771-2782
2023
-
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study
Melanoma research, Vol. 33, Núm. 5, pp. 388-397
-
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
International Journal of Molecular Sciences, Vol. 24, Núm. 13
-
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
European Journal of Cancer, Vol. 182, pp. 3-14
-
Study of Ferroptosis Transmission by Small Extracellular Vesicles in Epithelial Ovarian Cancer Cells
Antioxidants, Vol. 12, Núm. 1
-
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
Cancers, Vol. 15, Núm. 11
2022
-
Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus
Clinical and Translational Oncology, Vol. 24, Núm. 8, pp. 1515-1523
-
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 625-634
2020
-
Differential characteristics of HMGB2 versus HMGB1 and their perspectives in ovary and prostate cancer
Current Medicinal Chemistry, Vol. 27, Núm. 20, pp. 3271-3289
-
The HMGB1-2 ovarian cancer interactome. The role of HMGB proteins and their interacting partners MIEN1 and NOP53 in ovary cancer and drug-response
Cancers, Vol. 12, Núm. 9, pp. 1-22
-
The challenges and opportunities of lncRNAs in ovarian cancer research and clinical use
Cancers, Vol. 12, Núm. 4
2019
2015
-
Trombosis venosa de localización atípica en pacientes con cáncer
Medicina Clinica, Vol. 144, Núm. S1, pp. 38-40
2014
-
Angiosarcoma irresecable tratado con bevacizumab y paclitaxel
Actas Dermo-Sifiliograficas
-
MicroARN circulantes en sangre de pacientes con cáncer de próstata
Actas Urologicas Espanolas, Vol. 38, Núm. 10, pp. 633-639
2013
-
Importancia de los distintos tipos histológicos en el CPNCP
Revisiones en Cancer
2010
-
Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients
Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440